What podcasts say about CSL
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about CSL
8 statements · 7 positive · 1 negative
CSL is an industry-leading business in blood plasma and vaccines.
“It's a wonderful business, blood plasma vaccines, all that sort of stuff. It's an industry leader.”
Open the episode · Rates rise around the world, why the Aged Pension isn't enough & Pimp my Portfolio with Owen RaskListen at 31:42
CSL was sufficiently underpriced to justify maximum portfolio exposure and subsequently rallied sharply.
“We were maximum CSL across all our funds. And since then, it's had this astonishing rally.”
Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunityListen at 14:00
CSL shares rose 38% in one month after its reporting result.
“the stock just, you know, it was up 38% in a month.”
Open the episode · Hofflin: Big moves are creating great value on the ASXListen at 14:14
CSL was recently considered very cheap by Hofflin.
“In principle, two or three months ago I would have said, easy, CSL, right? This is so cheap.”
Open the episode · Hofflin: Big moves are creating great value on the ASXListen at 38:17
CSL could recover after its temporary earnings setback.
“This CSL could be a similar story.”
Open the episode · Data centre resistance grows, CSL is (sort of) back & a stock picker joins Pimp my PortfolioListen at 18:55
CSL shares rose 18% amid touted new drug developments.
“CSL is up 18% as they tout some new drug developments.”
Open the episode · BHP Rises, Tokyo Electron Down, Alibaba UpListen at 1:10
CSL shares rose 18% amid new drug developments and a planned reset quarter.
“CSL is up 18% as they tout some new drug developments and plan a reset quarter as they call it.”
Open the episode · BHP Rises, Tokyo Electron Down, Alibaba UpListen at 1:25
CSL remains substantially below its near-300 peak price.
“it's still considerably down from its sort of near 300 peak.”
Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael BurryListen at 13:12
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.